The Stanley Medical Research Institute
- Assets
- $85.7m
- Revenue
- $4.6m
- Investments
- $1.4m
- Employees
- 11
- Location
- Rockville, MD
- Founding
- 10/2001
- Data as of
- 12/2023
- EIN
- 06-1610506
Organization Overview
The Stanley Medical Research Institute is located in Rockville, MD. The organization was established in 2001. According to its NTEE Classification (H48) the organization is classified as: Brain Disorders Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Stanley Medical Research Institute employed 11 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Stanley Medical Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Stanley Medical Research Institute generated $4.6m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 9 years, the organization has seen revenues fall by an average of (10.1%) each year. All expenses for the organization totaled $6.6m during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (13.5%) per year over the past 9 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Stanley Medical Research Institute has awarded 211 individual grants totaling $60,065,795. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
SEE PART III, LINE 1.
Describe the Organization's Program Activity:
Part 3 - Line 4a
INFECTIOUS AND NEUROVIROLOGY: SMRI IS THE MAJOR RESEARCH INSTITUTION IN THE WORLD FOCUSING ON INFECTIOUS AGENTS AS A POSSIBLE CAUSE OF SCHIZOPHRENIA AND BIPOLAR DISORDER. THE CENTER FOR THIS RESEARCH IS THE STANLEY LABORATORY OF DEVELOPMENTAL NEUROVIROLOGY AT JOHNS HOPKINS UNIVERSITY IN BALTIMORE. THIS LABORATORY WORKS CLOSELY WITH SMRI-FUNDED RESEARCHERS AT SEVERAL OTHER INSTITUTIONS. THE MAIN TARGETS OF THIS RESEARCH ARE TOXOPLASMA GONDII, THE HERPES FAMILY OF VIRUSES, AND ENDOGENOUS RETROVIRUSES.
TREATMENT ADVOCACY CENTER
TREATMENT TRIALS: DURING 2023, SMRI SUPPORTED 21 TRIALS FOR THE TREATMENT OF SCHIZOPHRENIA OR BIPOLAR DISORDER. MOST OF THESE WERE DRUGS THAT ARE AVAILABLE TO TREAT OTHER CONDITIONS AND FOR WHICH THERE WAS REASON TO BELIEVE THEY MIGHT ALSO BE EFFECTIVE FOR PSYCHIATRIC DISORDERS. IN ALMOST ALL CASES, PHARMACEUTICAL COMPANIES ARE UNLIKELY TO SUPPORT SUCH TRIALS BECAUSE THE DRUG IS ALREADY GENERIC OR CANNOT BE PATENTED. SMRI IS SUPPORTING MORE SUCH TREATMENT TRIALS THAN ANY OTHER ORGANIZATION IN THE WORLD.
NEUROPATHOLOGY: BRAIN TISSUE REPOSITORY AND NEUROPATHOLOGY LABORATORY: STORES AND PROCESSES POSTMORTEM BRAIN TISSUE, LIVER, SPLEEN, SERUM AND CSF FROM PEOPLE WITH SCHIZOPHRENIA, BIPOLAR DISORDER, MAJOR DEPRESSION AND FROM NORMAL CONTROL SUBJECTS. SAMPLES ARE MADE AVAILABLE TO SCIENTISTS AROUND THE WORLD. ALL RESEARCH DATA COLLECTED ON THE SPECIMENS IS RETURNED TO THE SMRI PUBLICALLY AVAILABLE WEB-BASED INTERACTIVE NEUROPATHOLOGY DATABASE FOR FURTHER ANALYSIS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Maree J Webster See Sched L Executive Director | OfficerTrustee | 40 | $224,382 |
Robert Yolken See Sched O Trustee | Trustee | 5 | $36,000 |
E Fuller Torrey See Sched O Associate Director For Rea | Trustee | 24 | $24,660 |
Steven Jones Trustee | Trustee | 0.1 | $0 |
Barbara Torrey Trustee | Trustee | 0.1 | $0 |
Jonathan Stanley Trustee | Trustee | 0.1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $13,900 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $13,900 |
| Total Program Service Revenue | $0 |
| Investment income | $1,634,512 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $6,051 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $2,972,629 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $4,628,611 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $3,826,770 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $777,755 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $328,169 |
| Compensation of current officers, directors, key employees. | $82,192 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $567,121 |
| Pension plan accruals and contributions | $36,081 |
| Other employee benefits | $71,394 |
| Payroll taxes | $64,307 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $39,067 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $211,275 |
| Advertising and promotion | $0 |
| Office expenses | $23,060 |
| Information technology | $3,230 |
| Royalties | $0 |
| Occupancy | $475,040 |
| Travel | $15,922 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $1,047 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $6,185 |
| Insurance | $40,126 |
| All other expenses | $12,948 |
| Total functional expenses | $6,605,151 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $765,500 |
| Savings and temporary cash investments | $52,661,146 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $28,917 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $60,307 |
| Net Land, buildings, and equipment | $36,975 |
| Investments—publicly traded securities | $30,718,309 |
| Investments—other securities | $1,431,471 |
| Investments—program-related | $0 |
| Intangible assets | $7,599 |
| Other assets | $0 |
| Total assets | $85,710,224 |
| Accounts payable and accrued expenses | $27,675 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $193,657 |
| Total liabilities | $221,332 |
| Net assets without donor restrictions | $85,488,892 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $85,710,224 |
Grants Awarded
Over the last fiscal year, The Stanley Medical Research Institute has awarded $3,826,770 in support to 11 organizations.
| Grant Recipient | Amount |
|---|---|
JOHNS HOPKINS UNIVERSITY - RHY PURPOSE: NEUROVIROLOGY STUDIES-EARMARKED FOR DR.YOLKEN | $2,525,950 |
SHEPPARD PRATT PURPOSE: NEUROVIROLOGY STUDIES-EARMARKED FOR DR.DICKERSON AND TREATMENT TRIALS-EARMARKED FOR DR.DICKERSON | $599,262 |
THE REGENTS OF THE UNIV OF CALIFORNIA PURPOSE: TREATMENT TRIALS-EARMARKED FOR DR.MARDER | $114,254 |
UNIVERSITY OF MARYLAND BALTIMORE - RB PURPOSE: TREATMENT TRIALS-EARMARKED FOR DR.BUCHANAN | $101,570 |
UT SOUTHWESTERN MEDICAL CENTER - SB PURPOSE: TREATMENT TRIALS-EARMARKED FOR DR.BROWN | $78,343 |
VANPELT BIOSCIENCES LLC PURPOSE: NEUROVIROLOGY STUDIES-EARMARKED FOR DR.FORD | $75,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
The Stanley Medical Research Institute Rockville, MD | $85,710,224 | $4,628,611 |
Snyder-Robinson Foundation McLean, VA | $158,268 | $58,730 |
International Neuroethics Society Bethesda, MD | $210,685 | $174,158 |
Mind Your Brain Berwyn, PA | $132,736 | $133,198 |
Laney Jaymes Foundation Annapolis, MD | $21,796 | $41,811 |
Jess Fin Foundation Zionsville, PA | $11,847 | $29,775 |
Institute Of Chronic Illnesses Inc Silver Spring, MD | $17,853 | $144 |
Brain Injury Foundation Bala Cynwyd, PA | $630 | $100 |
Green Wave Foundation Inc Bel Air, MD | $0 | $0 |